Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Jiani WuDongqiang ZengShimeng ZhiZilan YeWenjun QiuNa HuangLi SunChunlin WangZhenzhen WuJianping BinYulin LiaoMin ShiWang-Jun LiaoPublished in: Journal of translational medicine (2021)
TEXscore capturing tumor-derived exosome features might be a robust biomarker for prognosis and treatment responses in independent cohorts.